Skip to main content

Clinical and microbial characterization of toxigenic Clostridium difficile
isolated from antibiotic associated diarrhea in Egypt

Research Authors
Sherein G. Elgendy1*, Sherine A. Aly1, Rawhia Fathy1, Enas A.E. Deaf1, Naglaa H. Abu Faddan2,Muhamad R. Abdel Hameed3
Research Department
Research Journal
Iranian Journal of Microbiology
Research Publisher
NULL
Research Rank
1
Research Vol
Vol. 12 - NO. 4
Research Website
NULL
Research Year
2020
Research_Pages
pp. 296-304
Research Abstract

Clostridium difficile infection (CDI) has become a significant healthcare-associated infection
throughout the world and is particularly important in developing countries. This study aimed to investigate clinical characterization and risk factors related to toxigenic C. difficile infection in adult and pediatric patients, antimicrobial susceptibility pattern. Also, to evaluate different diagnostic methods for rapid detection of C. difficile associated diarrhea (CDAD)
in Egypt.
Materials and Methods: Stool samples were collected from 95 pediatric patients and 37 adult patients suffering from antibiotic associated diarrhea and were subjected to direct toxin immunoassay and culture on cycloserine/cefoxitin/fructose agar.
The presence of tcdA and tcdB genes was tested by PCR.
Results: Toxigenic C. difficile was isolated from pediatric and adult patients at a rate of 17.89% (17/95) and 27% (10/37)
respectively. The sensitivity and specificity of direct PCR from stool are (100%, 100% and 82.4%, 100%) in adult and pediatric samples respectively. The susceptibility of C. difficile to vancomycin and metronidazole were found to be 66.7% and
48.2% respectively.
Conclusion: Diabetes mellitus, prior antibiotic treatment, hematological malignancy on chemotherapy, malnutrition, neutropenia and Ryle feeding are risk factors for development of CDAD. Tight restriction of unnecessary antibiotic uses is
necessary in our locality. Direct detection of toxin genes in stool by PCR is sensitive and specific method for early detection
of C. difficile.